Brief: InDex Pharmaceuticals Q1 EBIT SEK -5.3 Million
26/04/2024 07:01
Apr 26 (Reuters) - InDex Pharmaceuticals Q1 sales SEK 10.8 million. * Q1 cash flow from operating activities SEK -33.7 million * Q1 adjusted EPS SEK -0.01 * Q1 net income SEK -3 million
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen